Drug Type Small molecule drug |
Synonyms LPM526000133, LY03017 |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delusions | Phase 1 | CN | 17 May 2024 | |
Hallucinations | Phase 1 | CN | 17 May 2024 | |
Alzheimer Disease | Phase 1 | CN | 10 May 2024 | |
Parkinson Disease | Phase 1 | CN | 10 May 2024 | |
Schizophrenia | Phase 1 | CN | 10 May 2024 |